Cite
MLA Citation
Markus Axelsson et al.. “Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies.” Acta neurologica Scandinavica, vol. 139, 2019, pp. 422–427. http://access.bl.uk/ark:/81055/vdc_100080187990.0x000063
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Markus Axelsson et al.. “Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies.” Acta neurologica Scandinavica, vol. 139, 2019, pp. 422–427. http://access.bl.uk/ark:/81055/vdc_100080187990.0x000063